3 articles - Page 1/1
Risque thrombotique et anticoagulation des patients hospitalisés pour une maladie à Coronavirus 2019 sévère.
Thrombotic risk and anticoagulation in patients hospitalized for severe Coronavirus 2019 disease.
Auteurs/Authors : Labbe V., Mekontso-Dessap A.
Mots-clés : COVID-19, Pneumopathie hypoxémiante, Thromboses macrovasculaires, Thromboses microvasculaires, Anticoagulation, Prévention, Evénements thrombotiques, Essais cliniques : ANTICOVID, INSPIRATION, ACTION, COVIDOSE, REMAPCAP, ATTAC, ACTIV-4
Keywords: COVID-19, Hypoxemic lung disease, Macrovascular thrombosis, Microvascular thrombosis, Anticoagulation, Prevention, Thrombotic events, Clinical trials: ANTICOVID, INSPIRATION, ACTION, COVIDOSE, REMAPCAP, ATTAC, ACTIV-4
Étude de l'incidence de la maladie thromboembolique veineuse des membres inférieurs asymptomatique survenant sous anticoagulation chez les patients hospitalisés pour pneumopathie à COVID-19.
Incidence of asymptomatic venous thromboembolic disease of the lower limbs occurring under anticoagulation in medical inpatients with COVID-19 pneumonia.
Auteurs/Authors : Suhl J., Le Jeune S.
Mots-clés : COVID-19, Maladie veineuse thromboembolique
Keywords: COVID-19, Venous thromboembolism
Incidence de la maladie thromboembolique veineuse chez les patients hospitalisés pour COVID-19.
Incidence of venous thromboembolism in hospitalized COVID-19 patients.
Auteurs/Authors : Lambach H., Tousch J., Jambert L., Frantz A.S., Mirea C., Schini-Kerth V., Bilbault P., Meziani F., Ohlmann P., Andres E., Stephan D., Cordeanu M.
Mots-clés : MTEV, COVID-19, Registre
Keywords: Venous thromboembolism, COVID-19, Registry
